Literature DB >> 9303234

Reporting vaccine-associated adverse events.

P Duclos1, J Hockin, R Pless, B Lawlor.   

Abstract

OBJECTIVE: To determine family physicians' awareness of the need to monitor and report vaccine-associated adverse events (VAAE) in Canada and to identify mechanisms that could facilitate reporting.
DESIGN: Mailed survey.
SETTING: Canadian family practices. PARTICIPANTS: Random sample of 747 family physicians. Overall response rate was 32% (226 of 717 eligible physicians). MAIN OUTCOME MEASURES: Access to education on VAAE; knowledge about VAAE monitoring systems, reporting criteria, and reporting forms; method of reporting VAAEs and reasons for not reporting them; and current experience with VAAEs.
RESULTS: Of 226 respondents, 55% reported observing VAAEs, and 42% reported the event. Fewer than 50% were aware of a monitoring system for VAAE, and only 39% had had VAAE-related education during medical training. Only 28% knew the reporting criteria. Reporting was significantly associated with knowledge of VAAE monitoring systems and reporting criteria (P < 0.01).
CONCLUSION: Physicians need more feedback and education on VAAE reporting and more information about the importance of reporting and about reporting criteria and methods.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303234      PMCID: PMC2255353     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  7 in total

1.  Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Authors:  H D Scott; A Thacher-Renshaw; S E Rosenbaum; W J Waters; M Green; L G Andrews; G A Faich
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272

2.  Rhode Island physicians' recognition and reporting of adverse drug reactions.

Authors:  H D Scott; S E Rosenbaum; W J Waters; A M Colt; L G Andrews; J P Juergens; G A Faich
Journal:  R I Med J       Date:  1987-07

3.  Physician knowledge, attitudes, and behavior related to reporting adverse drug events.

Authors:  A S Rogers; E Israel; C R Smith; D Levine; A M McBean; C Valente; G Faich
Journal:  Arch Intern Med       Date:  1988-07

4.  Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom.

Authors:  K J Belton; S C Lewis; S Payne; M D Rawlins; S M Wood
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

5.  Adverse events temporally associated with immunizing agents.

Authors:  P Duclos; R Pless; J Koch; M Hardy
Journal:  Can Fam Physician       Date:  1993-09       Impact factor: 3.275

Review 6.  Current thoughts on the risks and benefits of immunisation.

Authors:  P Duclos; A Bentsi-Enchill
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

7.  [Postmarketing surveillance of secondary effects of vaccines].

Authors:  P Duclos
Journal:  Rev Epidemiol Sante Publique       Date:  1994       Impact factor: 1.019

  7 in total
  1 in total

1.  Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study.

Authors:  Adriana Parrella; Annette Braunack-Mayer; Michael Gold; Helen Marshall; Peter Baghurst
Journal:  BMC Health Serv Res       Date:  2013-08-15       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.